Mosaic Family Wealth’s Standard BioTools LAB Stock Holding History

Mosaic Family Wealth’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-700	Closed	-$9K	–	404
2019 Q1	$9K	Hold	700	–	–	﹤0.01%	506
2018 Q4	$6K	Hold	700	–	–	﹤0.01%	537
2018 Q3	$5K	Hold	700	–	–	﹤0.01%	555
2018 Q2	$4K	Hold	700	–	–	﹤0.01%	604
2018 Q1	$4K	Hold	700	–	–	﹤0.01%	595
2017 Q4	$4K	Hold	700	–	–	﹤0.01%	611
2017 Q3	$4K	Hold	700	–	–	﹤0.01%	752
2017 Q2	$3K	Hold	700	–	–	﹤0.01%	642
2017 Q1	$4K	Hold	700	–	–	﹤0.01%	617
2016 Q4	$5K	Hold	700	–	–	﹤0.01%	557
2016 Q3	$6K	Hold	700	–	–	﹤0.01%	559
2016 Q2	$7K	Hold	700	–	–	﹤0.01%	564
2016 Q1	$5K	Hold	700	–	–	﹤0.01%	598
2015 Q4	$7K	Buy	+700	New	+$6.87K	﹤0.01%	564

Other funds holding LAB

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mosaic Family Wealth's LAB Position: Q2 2019 in Review

Mosaic Family Wealth sold out of Standard BioTools (LAB) in Q2 2019, closing a stake of 700 shares — an estimated $9K sold.

Mosaic Family Wealth first reported a position in LAB in Q4 2015 and held it in 14 quarters. The position peaked at $9K in Q1 2019. 135 funds tracked by Wall St. Rank hold LAB as of Q2 2019.

Mosaic Family Wealth reported no remaining Standard BioTools position as of Q2 2019 after selling out during the quarter.
Mosaic Family Wealth sold 700 Standard BioTools shares in Q2 2019, an estimated $9K.
Mosaic Family Wealth first reported a position in Standard BioTools in Q4 2015 and held it in 14 quarters.
Mosaic Family Wealth's Standard BioTools position peaked at $9K in Q1 2019.
135 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2019.

Based on Mosaic Family Wealth's 13F filing for Q2 2019, filed 12 Aug 2019.